Economics and decisions to end life: van Acht and Stooker revisited.
Debates about euthanasia have tended to exclude any economic arguments. This might be due to the narrow perspective of the economic arguments presented to date, most of which focus on the health care costs in the last year of life. This paper considers the wider economic aspects in decisions to end life, including potential methodological weaknesses in measuring costs in the last year of life, the costs of euthanasia itself, the value of patient preferences and the value (and problems) of choice. Suggestions are made on how these economic issues might be explored to take the economic arguments forward.
Scuffham
Paul A
PA
York Health Economics Consortium Ltd, Level 2, Market Square, University of York, York, England YO10 5NH. pas8@york.ac.uk
Taylor
Matthew J
MJ
D003657:Decision Making; D005065:Euthanasia; D017048:Health Care Costs; D006801:Humans; D009426:Netherlands; D017060:Patient Satisfaction; D019057:Quality-Adjusted Life Years; D013222:State Medicine / Q000191:economics; D017236:Suicide, Assisted; D013727:Terminal Care / Q000191:economics*; D006113:United Kingdom